Pharvaris N.V.

PHVS chart

Pharvaris N.V. news

• PHVS: 2027 brings an on-demand FDA decision, prophylaxis filing plans and CREATE readout

  TradingView · Nov 9, 2:55 PM EST

• Pharvaris N.V. (PHVS) Options Chain - Yahoo Finance

  Yahoo! Finance Canada · Nov 8, 11:23 AM EST

• Pharvaris (PHVS) Stock Could Look Pricey Following Phase 3 Momentum

  Yahoo Finance · Nov 4, 10:11 AM EST

• Pharvaris to Present Clinical and Real-World Data at the ACAAI 2026 Annual Scientific Meeting

  Yahoo Finance · Oct 29, 6:50 AM EDT

• Bank of America backs Pharvaris on breakthrough for rare swelling disease

  thestreet.com · Oct 26, 7:00 PM EDT

• Norwegian downgraded, Skydance upgraded: Wall Street's top analyst calls

  Yahoo Finance · Oct 23, 9:57 AM EDT

• BioCryst (BCRX) Trades at Just 11x Forward Earnings. Is the Market Pricing In Trouble?

  Yahoo Finance · Oct 15, 2:05 PM EDT

• Phase 3 Study Results Highlighting Deucrictibant’s Rapid and Sustained Efficacy in Treating HAE Attacks Published in The Lancet

  Yahoo Finance · Oct 8, 6:35 PM EDT

• Could Real-World HAE Oral Preference Data Be a Pivotal Signal for Pharvaris' (PHVS) Strategy?

  Yahoo Finance · Oct 8, 11:10 AM EDT

• Real-World Analysis Highlighting HAE Disease Experience and Gaps in Treatment Satisfaction Published in Advances in Therapy

  Yahoo Finance · Oct 5, 6:50 AM EDT

• What Does Pharvaris (PHVS) Phase 3 HAE Success Mean Now?

  Yahoo Finance · Sep 19, 11:12 AM EDT

• BioCryst Eyes $1B Rare-Disease Future Through External Innovation

  marketbeat.com · Sep 18, 10:01 PM EDT

Pharvaris N.V. key financials

No XBRL financial data is available for this company yet.

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 6-K6-K2026-09-08
• 6-K6-K2026-09-08
• 6-K6-K2026-08-12
• 6-K6-K2026-06-26
• 6-K6-K2026-06-11
• 6-K6-K2026-05-12
• 6-K6-K2026-05-11
• 20-F20-F2026-04-02
• 6-K6-K2026-04-02
• 6-K6-K2026-01-12
• 6-K6-K2025-12-03
• 6-K6-K2025-11-12

About Pharvaris N.V.

Ticker

PHVS (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

Leiden

Incorporated in

Netherlands

Fiscal year end

December 31

SEC CIK

1830487

Former names

Pharvaris, B.V.

Frequently asked questions